Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population

References

• Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immunosuppressive agent. Am J Heal Syst Pharm 1995;52: 1521–35.
   PubMed Web of Science ®Google Scholar
• Weir MR, Mulgaonkar S, Chan L, Shidban H, Waid TH, Preston D, et al. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial. Kidney Int 2011;79:897–907.
   PubMed Web of Science ®Google Scholar
• Van Leeuwen MT, Webster AC, McCredie MRE, Stewart JH, McDonald SP, Amin J, et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ 2010; 340:c570.
   Web of Science ®Google Scholar
• Neff RT, Jindal RM, Yoo DY, Hurst FP, Agodoa LY, Abbott KC. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 2009;88: 135–41.
   PubMed Web of Science ®Google Scholar
• Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant 2006;20:401–9.
   PubMed Web of Science ®Google Scholar
• Grimaldi A, Barletta A, Rascente M, Pisani F, Iaria G, Maccarone D, et al. Infectious complications in the renal transplant recipient. Transplant Proc 2005;37:2502–3.
   PubMed Web of Science ®Google Scholar
• Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand MR. Infectious complications after kidney transplantation: a single-center experience. Transpl Infect Dis 2007;9:302–9.
   PubMed Web of Science ®Google Scholar
• Gunst JD, Jensen-Fangel S, Jespersen B, Ostergaard L, Søgaard OS. Central nervous system infections among individuals with and without end-stage renal disease. J Infect 2013;67:19–26.
   PubMed Web of Science ®Google Scholar
• Nielsen LH, Jensen-Fangel S, Jespersen B, Ostergaard L, Søgaard OS. Risk and prognosis of hospitalization for pneumonia among individuals with and without functioning renal transplants in Denmark: a population-based study. Clin Infect Dis 2012;55:679–86.
   PubMed Web of Science ®Google Scholar
• Afessa B. Pulmonary complications of HIV Infection. Chest J 1998;113:1225.
   PubMed Web of Science ®Google Scholar
• Meuwissen JH, Tauber I, Leeuwenberg AD, Beckers PJ, Sieben M. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis 1977;136:43–9.
   PubMed Web of Science ®Google Scholar
• Ponce CA, Gallo M, Bustamante R, Vargas SL. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 2010;50:347–53.
   PubMed Web of Science ®Google Scholar
• Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001;32:855–61.
   PubMed Web of Science ®Google Scholar
• Hirschl MM, Derfler K, Janata O, Heinz G, Sertl K, Balcke P. Accumulation of Pneumocystis carinii pneumonia in patients after kidney transplantation. Clin Nephrol 1992; 37:105.
   PubMed Web of Science ®Google Scholar
• Schmoldt S, Schuhegger R, Wendler T, Huber I, Söllner H, Hogardt M, et al. Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation. J Clin Microbiol 2008;46: 966–71.
   PubMed Web of Science ®Google Scholar
• De Boer MGJ, Bruijnesteijn van Coppenraet LES, Gaasbeek A, Berger SP, Gelinck LBS, van Houwelingen HC, et al. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis 2007;44:1143–9.
   PubMed Web of Science ®Google Scholar
• De Boer MGJ, de Fijter JW, Kroon FP. Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review. Med Mycol 2011;49: 673–80.
   PubMed Web of Science ®Google Scholar
• Fishman JA; AST Infectious Diseases Community of Practice. Introduction: infection in solid organ transplant recipients. Am J Transplant 2009;9(Suppl 4):S3–6.
   PubMed Web of Science ®Google Scholar
• Rostved AA, Sassi M, Kurtzhals JA, Sørensen SS, Rasmussen A, Ross C, et al. Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii. Transplantation 2013;96:834–42.
   PubMed Web of Science ®Google Scholar
• Shelhamer JH, Gill VJ, Quinn TC, Crawford SW, Kovacs JA, Masur H, et al. The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 1996;124:585–99.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2009;135: 655–61.
   PubMed Web of Science ®Google Scholar
• Hui M, Kwok WT. Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study. J Med Microbiol 2006; 55:85–8.
   PubMed Web of Science ®Google Scholar
• Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989;11:954–63.
   PubMedGoogle Scholar
• El-Faramawi M, Rohr N, Jespersen B. Steroid-free immunosuppression after renal transplantation – long-term experience from a single centre. Nephrol Dial Transplant 2006;21: 1966–73.
   PubMed Web of Science ®Google Scholar
• Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999;28:240–6.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 2004;17:770–82, table of contents.
   PubMed Web of Science ®Google Scholar
• Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995;162: 233–5.
   PubMed Web of Science ®Google Scholar
• Radisic M, Lattes R, Chapman JF, del Carmen Rial M, Guardia O, Seu F, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis 2003;5:84–93.
   PubMedGoogle Scholar
• Benedetti E, Sileri P, Pursell KJ, Giacomoni A, Tzoracoleftherakis E, Rastellini C, et al. Treatment of severe pneumonia in kidney transplant recipients. Transplant Proc 2001; 33:3652.
   PubMed Web of Science ®Google Scholar
• De Boer MGJ, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis 2011; 13:559–69.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010;77:299–311.
   PubMed Web of Science ®Google Scholar
• European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia. Nephrol Dial Transplant 2002;17(Suppl 4): 36–9.
   PubMedGoogle Scholar
• Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 2013;13(Suppl 4): 272–9.
   PubMed Web of Science ®Google Scholar
• Dominguez J, Mahalati K, Kiberd B, McAlister VC, MacDonald AS. Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. Transplantation 2000;70:1244–7.
   PubMed Web of Science ®Google Scholar
• Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU, et al. Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant 2011;26:2013–7.
   PubMed Web of Science ®Google Scholar
• Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group. Transplantation 1999;68:1526–32.
   PubMed Web of Science ®Google Scholar
• Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 1996;62:421–3.
   Google Scholar
• Arichi N, Kishikawa H, Mitsui Y, Kato T, Nishimura K, Tachikawa R, et al. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc 2009;41:170–2.
   PubMed Web of Science ®Google Scholar
• Bensousan T, Garo B, Islam S, Bourbigot B, Cledes J, Garre M. Possible transfer of Pneumocystis carinii between kidney transplant recipients. Lancet 1990;336:1066–7.
   PubMed Web of Science ®Google Scholar
• Gianella S, Haeberli L, Joos B, Ledergerber B, Wüthrich RP, Weber R, et al. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis 2010;12:1–10.
   PubMed Web of Science ®Google Scholar